Suppr超能文献

胚胎性横纹肌肉瘤的致密模式,一种容易与肺泡横纹肌肉瘤混淆的病变:儿童肿瘤学组软组织肉瘤委员会的报告。

Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

机构信息

Seattle Children's Hospital, Department of Laboratories, M/S OC.8.720, 4800 Sandpoint Way NE, Seattle, WA 98015, USA.

出版信息

Am J Clin Pathol. 2013 Jul;140(1):82-90. doi: 10.1309/AJCPA1WN7ARPCMKQ.

Abstract

OBJECTIVES

To examine whether the frequency of fusion-negative alveolar rhabdomyosarcoma (ARMSn) increased coincident with changes in the definition of alveolar histology.

METHODS

We re-reviewed alveolar rhabdomyosarcoma (ARMS) in the Children's Oncology Group study D9803, comparing histopathology with fusion status.

RESULTS

Our review of 255 original ARMS cases (compared with a control group of 38 embryonal rhabdomyosarcomas [ERMS] cases) revealed that many had an ARMS-like densely cellular pattern with cytologic features and myogenin expression more typical of ERMS. Following re-review, 84 (33%) cases of original ARMS were rediagnosed as ERMS. All reclassified ERMS, including dense ERMS, were fusion negative, whereas 82% of confirmed ARMS cases were fusion positive. Total ARMS diagnoses returned to historic rates of 25% to 30% of all rhabdomyosarcomas, and ARMSn decreased from 37% to 18% of ARMS cases. The outcome of reclassified ERMS was similar to confirmed ERMS.

CONCLUSIONS

To address the role of fusion status in risk stratification, pathologists should include both a histologic diagnosis and an evaluation of fusion status for all new ARMS diagnoses.

摘要

目的

探讨融合阴性肺泡横纹肌肉瘤(ARMSn)的频率是否随着肺泡组织学定义的改变而增加。

方法

我们重新审查了儿童肿瘤学组研究 D9803 中的肺泡横纹肌肉瘤(ARMS),比较了组织病理学与融合状态。

结果

我们对 255 例原始 ARMS 病例(与 38 例胚胎性横纹肌肉瘤 [ERMS] 病例的对照组进行比较)进行了回顾性分析,结果发现许多病例具有类似于 ARMS 的致密细胞模式,具有更典型的 ERMS 的细胞学特征和肌球蛋白表达。重新审查后,84 例(33%)原始 ARMS 病例被重新诊断为 ERMS。所有重新分类的 ERMS,包括致密 ERMS,均为融合阴性,而 82%的确诊 ARMS 病例为融合阳性。总的 ARMS 诊断率恢复到历史上所有横纹肌肉瘤的 25%至 30%,ARMSn 从 ARMS 病例的 37%降至 18%。重新分类的 ERMS 的结果与确诊的 ERMS 相似。

结论

为了在风险分层中考虑融合状态的作用,病理学家应为所有新的 ARMS 诊断同时提供组织学诊断和融合状态评估。

相似文献

2
Classification of rhabdomyosarcoma and its molecular basis.
Adv Anat Pathol. 2013 Nov;20(6):387-97. doi: 10.1097/PAP.0b013e3182a92d0d.
4
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
J Clin Oncol. 2010 May 1;28(13):2151-8. doi: 10.1200/JCO.2009.26.3814. Epub 2010 Mar 29.
7
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.
Pediatr Blood Cancer. 2013 Sep;60(9):1411-7. doi: 10.1002/pbc.24532. Epub 2013 Mar 22.
10
Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Cancer Res. 2006 May 1;66(9):4742-9. doi: 10.1158/0008-5472.CAN-05-4292.

引用本文的文献

1
Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications.
Front Oncol. 2025 Jun 17;15:1570070. doi: 10.3389/fonc.2025.1570070. eCollection 2025.
2
Case Report: F-FDG PET/CT revealed diffuse pancreatic metastasis in paranasal sinuses rhabdomyosarcoma after treatment improvement.
Front Med (Lausanne). 2025 May 30;12:1609837. doi: 10.3389/fmed.2025.1609837. eCollection 2025.
3
Rhabdomyosarcoma in children and young adults.
Virchows Arch. 2025 Jan;486(1):101-116. doi: 10.1007/s00428-024-03961-y. Epub 2024 Dec 18.
5
Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas.
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050704. Epub 2024 Jun 25.
6
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.
Cancers (Basel). 2023 Nov 2;15(21):5269. doi: 10.3390/cancers15215269.
7
Retroperitoneal alveolar rhabdomyosarcoma intruding into spinal canal: A case report and literature review.
Front Med (Lausanne). 2022 Nov 3;9:1019964. doi: 10.3389/fmed.2022.1019964. eCollection 2022.
10
Relapsed Rhabdomyosarcoma.
J Clin Med. 2021 Feb 17;10(4):804. doi: 10.3390/jcm10040804.

本文引用的文献

1
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.
Pediatr Blood Cancer. 2013 Sep;60(9):1411-7. doi: 10.1002/pbc.24532. Epub 2013 Mar 22.
4
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
J Clin Oncol. 2010 May 1;28(13):2151-8. doi: 10.1200/JCO.2009.26.3814. Epub 2010 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验